| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/08/2010 | WO2010076400A1 Use of an anti-cd20 antibody for treating primary intraocular lymphoma |
| 07/08/2010 | WO2010075986A1 Nitroprotein biomarkers for copd |
| 07/08/2010 | WO2010075891A1 Fibcd1 for the prevention and treatment of diseases |
| 07/08/2010 | WO2010075861A2 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
| 07/08/2010 | WO2010056991A8 Vaccine formulations and uses thereof |
| 07/08/2010 | WO2010047955A3 N-linked glycosylation alteration in e0 and e2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine |
| 07/08/2010 | WO2010045573A3 Tumor vaccine |
| 07/08/2010 | WO2010045431A3 Dry powder formulations, vaccines and methods |
| 07/08/2010 | WO2010043561A3 Regenerative therapy |
| 07/08/2010 | WO2010041938A3 New virulence factors of streptococcus pneumoniae |
| 07/08/2010 | WO2010041143A3 Oral vaccines for producing mucosal immunity |
| 07/08/2010 | WO2010039742A3 Methods to reduce b-helper t cells to treat autoimmune diseases |
| 07/08/2010 | WO2010033274A3 Nanoemulsion adjuvants |
| 07/08/2010 | WO2009053604A9 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 07/08/2010 | US20100174056 Recombinant tumor specific antibody and use thereof |
| 07/08/2010 | US20100173854 Microfluidized Oil-in-water Emulsions and Vaccine Compositions |
| 07/08/2010 | US20100173848 Methods of inhibiting chemokine binding to chemokines receptors |
| 07/08/2010 | US20100173388 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/08/2010 | US20100173297 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/08/2010 | US20100173005 Microparticle formulations for sustained-release of bioactive compounds |
| 07/08/2010 | US20100173004 Preventive and therapeutic vaccine for alzheimer's disease |
| 07/08/2010 | US20100172993 Particles for delivery of active ingredients, process of making and compositions thereof |
| 07/08/2010 | US20100172973 Pharmaceutical Composition |
| 07/08/2010 | US20100172968 Chimeric cannulae proteins and methods for making and using them |
| 07/08/2010 | US20100172962 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 07/08/2010 | US20100172940 Treatment of soft tissue injury using hyaluronic acid and botulinum toxin |
| 07/08/2010 | US20100172939 Treating neoplasms with neurotoxin |
| 07/08/2010 | US20100172938 Modified bacterial surface layer proteins |
| 07/08/2010 | US20100172937 Enveloped virus neutralizing compounds |
| 07/08/2010 | US20100172936 Chimeric papillomavirus-like particles |
| 07/08/2010 | US20100172935 Method for viral inoculation of the vestibular region of the nares |
| 07/08/2010 | US20100172934 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 07/08/2010 | US20100172933 Recombinant vectors based on the modified vaccinia ankara (mva) virus as vaccines against lieshmaniasis |
| 07/08/2010 | US20100172932 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes |
| 07/08/2010 | US20100172931 Pharmaceutical Composition Containing the NMB1796 Protein |
| 07/08/2010 | US20100172930 Transfection complexes |
| 07/08/2010 | US20100172929 Malaria Vaccines |
| 07/08/2010 | US20100172928 Recombinant viral-based malaria vaccines |
| 07/08/2010 | US20100172927 Vaccines Against Chlamydial Infection |
| 07/08/2010 | US20100172926 Anthrax compositions and methods of use and production |
| 07/08/2010 | US20100172925 Hla-a2-restricted t-cell epitopes of the respiratory syncytial virus fusion protein as peptide-based vaccines |
| 07/08/2010 | US20100172924 Circovirus sequences associated with piglet weight loss disease (pwd) |
| 07/08/2010 | US20100172923 Protein Composition for Inducing an Immune Response in a Vertebrate Comprising a Plurality of Protein Variants Covering the Heterogeneity of a Single Antigen, AMA1 |
| 07/08/2010 | US20100172922 Expression and Purification of HIP/PAP and Uses Therefor |
| 07/08/2010 | US20100172921 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
| 07/08/2010 | US20100172920 Method of inducing immune tolerance to type i diabetes |
| 07/08/2010 | US20100172919 Noveltreatment for neurological disorders |
| 07/08/2010 | US20100172918 Novel lysin protein having broad antibacterial activity specific to bacteria |
| 07/08/2010 | US20100172917 Binding molecules against SARS-coronavirus and uses thereof |
| 07/08/2010 | US20100172916 Substituted hydroxyphenylamine compounds |
| 07/08/2010 | US20100172915 Compositions and methods of using angiopoietin-like 4 protein |
| 07/08/2010 | US20100172914 Methods and materials related to trail isoforms |
| 07/08/2010 | US20100172913 Fibrosis inhibitor |
| 07/08/2010 | US20100172912 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/08/2010 | US20100172911 Methods and Vectors for Generating Asialylated Immunoglobulins |
| 07/08/2010 | US20100172910 Human sarcoma-associated antigens |
| 07/08/2010 | US20100172909 Cerebral edema suppressant |
| 07/08/2010 | US20100172908 Methods and compositions for treating diseases targeting maba1 |
| 07/08/2010 | US20100172907 Anti-Abeta antibodies and their use |
| 07/08/2010 | US20100172906 Anti-herpes simplex virus antibodies and methods of use thereof |
| 07/08/2010 | US20100172905 Antagonists of hmg1 for treating inflammatory conditions |
| 07/08/2010 | US20100172904 Mcp1 fusions |
| 07/08/2010 | US20100172903 Combination of an Anti-Ep-CAM Antibody with a Chemotherapeutic Agent |
| 07/08/2010 | US20100172902 Method for treating a vcam-1 mediated disease |
| 07/08/2010 | US20100172901 Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment |
| 07/08/2010 | US20100172900 Human Monoclonal Antibodies to BTLA And Methods of Use |
| 07/08/2010 | US20100172899 IgM Production by Transformed Cell and Method of Quantifying the Same |
| 07/08/2010 | US20100172898 Microstructure synthesis by flow lithography and polymerization |
| 07/08/2010 | US20100172897 Diagnosis and Prevention of Fetal Heart Disease |
| 07/08/2010 | US20100172896 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 07/08/2010 | US20100172895 Human CGRP Receptor Binding Proteins |
| 07/08/2010 | US20100172894 Methods for purification of single domain antigen binding molecules |
| 07/08/2010 | US20100172893 Use of Reversine and Analogs For Treatment of Cancer |
| 07/08/2010 | US20100172867 Substituted 1h-pyrazolo[3,4-d]pyrimidine-6-amine compounds |
| 07/08/2010 | US20100172862 Stable antibody compositions and methods of stabilizing same |
| 07/08/2010 | US20100172838 Endometrial biomarkers |
| 07/08/2010 | US20100172837 MN Gene and Protein |
| 07/08/2010 | US20100172832 Diagnosis and treatment of malignant neoplasms |
| 07/08/2010 | CA2781805A1 Chlamydia antigens and uses thereof |
| 07/08/2010 | CA2771681A1 Immunoglobulin g composition |
| 07/08/2010 | CA2748562A1 Use of an immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies for treating neonatal jaundice caused by maternal-foetal incompatibility with respect to the abo system |
| 07/08/2010 | CA2747310A1 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof |
| 07/08/2010 | CA2747123A1 High affinity human antibodies to pcsk9 |
| 07/08/2010 | CA2746228A1 Modified rsv f proteins and methods of their use |
| 07/08/2010 | CA2740806A1 Anti-pd-l1 antibodies and their use to enhance t-cell function |
| 07/08/2010 | CA2738243A1 Formulations of single domain antigen binding molecules |
| 07/08/2010 | CA2737453A1 Combination gas vaccines and therapeutics |
| 07/07/2010 | EP2204452A1 Modified Vaccinia Ankara Virus variant |
| 07/07/2010 | EP2204448A1 Method of detecting liver cancer, diagnostic for liver cancer and remedy for cancer |
| 07/07/2010 | EP2204385A1 Pseudomonas exotoxin A mutants and uses thereof |
| 07/07/2010 | EP2204191A1 Monoclonal antibodies to hepatocyte growth factor |
| 07/07/2010 | EP2204190A1 IgM production by transformed cells and methods for quantifying said IgM production |
| 07/07/2010 | EP2204189A2 Allergen peptide fragments and use thereof |
| 07/07/2010 | EP2204188A1 Subunit vaccine against respiratory syncytial virus infection |
| 07/07/2010 | EP2204187A1 Human flu vaccine containing four influenza peptides |
| 07/07/2010 | EP2204186A1 Immunogenic complexes and methods relating thereto |
| 07/07/2010 | EP2204185A1 Combined meningitis vaccine |
| 07/07/2010 | EP2204184A1 Lawsonia vaccine and methods of use thereof |
| 07/07/2010 | EP2204180A2 Modified Vaccinia Virus Ankara for the vaccination of neonates |
| 07/07/2010 | EP2204179A2 Modified Vaccinia Virus Ankara for the vaccination of neonates |